INCR

Intercure Ltd.

• NASDAQ·06/23 07:40

  InterCure Secures NIS 22 Million In Private Placement Financing

• TipRanks·06/22 13:42

  InterCure Secures NIS 22 Million Private Placement to Fund Global Medical Cannabis Expansion

• Seeking Alpha·06/22 13:03

  InterCure secures up to NIS 54M financing

• Benzinga·06/22 12:54

  InterCure Enters Private Placement With Its CEO And Other Shareholders For Commitments Of ~$7.4M, With Option To Increase To ~$18.6M

• TipRanks·06/15 14:03

  InterCure Advances Global Push With Botanico Acquisition Tranche and U.S. Strategy Review

• Benzinga·06/15 13:26

  InterCure Reports Growing Demand In Germany And Evaluates Opportunities In Regulated U.S. Medical Cannabis Markets

• Reuters·06/15 13:25

  INTERCURE LTD: APPOINTED A GERMAN MANAGEMENT AND SALES TEAM AND ANTICIPATES MULTIPLE PRODUCT LAUNCHES IN SECOND HALF OF YEAR

• Reuters·06/15 13:25

  INTERCURE INITIATES STRATEGIC REVIEW OF U.S. MEDICAL CANNABIS OPPORTUNITIES FOLLOWING HISTORIC FEDERAL RESCHEDULING AND COMPLETES THE INITIAL CLOSING OF BOTANICO ACQUISITION

• Seeking Alpha·05/01 15:26

  InterCure reports FY results

• TipRanks·05/01 13:49

  InterCure Posts 2025 Revenue Growth, Positive Cash Flow as Recovery and Expansion Accelerate

• PUBT·04/20 20:02

  InterCure files Form 3 as director Alon Shmuel Granot reports initial ownership

• PUBT·04/20 20:02

  InterCure CEO Alexander Rabinovich files initial beneficial ownership statement

• PUBT·04/20 20:01

  InterCure director Lennie Michelson Grinbaum files initial beneficial ownership statement

• PUBT·04/16 20:02

  InterCure files Form 3 for CFO Amos Cohen beneficial ownership stake

• PUBT·04/16 20:01

  InterCure director David Salton files initial beneficial ownership statement